Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

68.98 +0.49 (+0.72%)
Official Closing Price Updated: 7:00 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
58 59 Next >
These 5 S&P 500 Winners Held Strong In Q1 — Can The Rally Continue?
A group of S&P 500 stocks have remained resilient as tariffs and earnings concerns cause the market to drop. Future gains may be limited. 
Via Benzinga
Topics Stocks World Trade
A Closer Look at CVS Health's Options Market Dynamics
Via Benzinga
FTC Pauses Lawsuit Against CVS, Cigna, UnitedHealth's PBMs Amid Commissioner Shortage
The FTC has paused its antitrust case against major PBMs, citing a lack of commissioners. The lawsuit alleges unfair practices that inflated insulin prices. 
Via Benzinga
Topics Lawsuit
SPX Nosedives 4.5%: Can ETFs Like SPY Weather The Market Storm?
SPX-USD lost over 4.5% in Q1 of 2025 due to economic uncertainty and trade war fears. Investor sentiment remains in Extreme Fear category. 
Via Benzinga
Topics ETFs World Trade
Is CVS Health Gaining or Losing Market Support?
Via Benzinga
CVS Health Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Has CVS Health Stock Turned Things Around?
Via The Motley Fool
Indications Suggest CVS HEALTH CORP (NYSE:CVS) Could Be on the Verge of a Breakout.
CVS HEALTH CORP (NYSE:CVS) has a strong technical rating of 9 out of 10, indicating a potential breakout. 
Via Chartmill
4 Healthcare Stocks With Massive Gains—and More to Come
Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year. 
Via MarketBeat
Topics Artificial Intelligence Economy World Trade
Health Insurance Providers Stocks Q4 Highlights: CVS Health (NYSE:CVS)
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including CVS Health (NYSE:CVS) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Is CVS Health Gaining or Losing Market Support?
Via Benzinga
Q4 Earnings Highlights: Cencora (NYSE:COR) Vs The Rest Of The Health Insurance Providers Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Cencora (NYSE:COR) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Deep Dive Into CVS Health Stock: Analyst Perspectives (8 Ratings)
Via Benzinga
Two Sectors Just Tried And Failed - And That’s Great For Us
Technology and healthcare have both tried for a breakout and failed, courtesy of massive economic forces rocking the boat. 
Via Talk Markets
Topics Stocks / Equities
No Quick Fix For This Market
Despite the pullback, we have found numerous opportunities which we discuss in this video using technical analysis. 
Via Talk Markets
Topics Stocks / Equities
This Is What Whales Are Betting On CVS Health
Via Benzinga
The S&P 500 Is Struggling, But These 3 Stocks Are Up More Than 25% This Year
Via The Motley Fool
Topics Stocks
Q4 Earnings Outperformers: Clover Health (NASDAQ:CLOV) And The Rest Of The Health Insurance Providers Stocks
Let’s dig into the relative performance of Clover Health (NASDAQ:CLOV) and its peers as we unravel the now-completed Q4 health insurance providers earnings season. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
CVS Stock Flashes Golden Cross As Weight Loss Program Delivers Big Results
CVS Health Corp. flashing bullish signal with Golden Cross formation and strong technicals. Weight management program also gaining traction. 
Via Benzinga
Allegations of Inflated Prescription Drug Costs Spark Employee Lawsuit Against JPMorgan
A lawsuit has been lodged against JPMorgan Chase by its employees, who claim that the company's prescription drug plan consented to pay exorbitant prices for medications. 
Via Benzinga
Topics Lawsuit
CVS Weight Management Program Yields 15% Average Weight Loss, 26% Cost Saving Among Participants
CVS Weight Management program members achieved 15% average weight loss, with 92% satisfaction and 26% lower GLP-1 medication costs for participating clients. 
Via Benzinga
Inflation Isn’t Going Away, But These Sectors Don’t Care
The CPI and PPI releases this week came in more or less at estimates - nothing to alarm the talking heads, anyway. They show inflation slowing down but not receding. 
Via Talk Markets
Topics ETFs Economy Stocks / Equities
Spotlight on CVS Health: Analyzing the Surge in Options Activity
Via Benzinga
Palantir Stock Climbs As Wall Street Eyes New Artificial Intelligence Customers At AIPCon
Palantir stock climbed as analysts focused on potential new customers such as Walgreens at an artificial intelligence event called AIPCon. 
Via Investor's Business Daily
Topics Artificial Intelligence
These 3 Dividend Stocks Jumped 15% in a Month—More to Come?
Via MarketBeat
Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet
Walgreens Boots Alliance agreed to an $11.45 per share buyout by Sycamore Partners, but shareholders can reject the deal and holdout for a better offer. 
Via MarketBeat
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
CVS Health (CVS): Buy, Sell, or Hold Post Q4 Earnings?
CVS Health has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.4%. The stock now trades at $65.60, marking a 15.2% gain. This was partly thanks to its solid... 
Via StockStory
Topics Stocks
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week
Speculation over an impending reverse merger, a Phase 2 trial announcement, comments about upcoming cancer screening tests, a Medicare business deal, and an obesity drug partnership sparked buzz among... 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9
...
58 59 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.